Company
Editas
Also known as Editas Medicine
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Editas Medicine is harnessing CRISPR-Cas9 gene editing to create genomic medicines for devastating and hard-to-treat diseases, including Usher syndrome and Duschenne muscular dystrophy.
Loading relationship preview